Veronika Weyerer
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.Miriam Angeloni, Thomas van Doeveren, Sebastian Lindner
|Jan 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.Veronika Bahlinger, Annalena Branz, Pamela L Strissel
|Sep 29, 2021
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort.Friederike Kullmann, Pamela L Strissel, Reiner Strick
|Aug 07, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.Markus Eckstein, Verena Lieb, Rudolf Jung
|Jul 02, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.Danijel Sikic, Helge Taubert, Ralph M Wirtz
Pageof 1
